Back to Trades
Gheuens Sarah
Chief Medical OfficerCIK 0001881190
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 7
- Companies
- 2
- Active
- 2025–2026
Across 8 filings between 2025–2026, Gheuens Sarah, Chief Medical Officer, has disclosed $3.1M in transactions — spread across 2 companies. Their disclosed trades are heavily weighted toward selling — $0 in buys and $1.8M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Aug 6 | AGIO AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah | Chief Medical Officer | Sell | $914.4K |
| Jul 2 | VRDN Viridian Therapeutics, Inc.\DE | Gheuens Sarah | Insider | Award | $597.7K |
| Jul 2 | AGIO AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah | Chief Medical Officer | Sell | $150.5K |
| Jun 23 | AGIO AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah | Chief Medical Officer | Exercise | $0 |
| Apr 6 | AGIO AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah | Chief Medical Officer | Sell | $102.0K |
| Nov 3 | AGIO AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah | Chief Medical Officer | Sell | $8.8K |
| Oct 29 | AGIO AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah | Chief Medical Officer | Sell | $145.0K |
| Jul 11 | AGIO AGIOS PHARMACEUTICALS, INC. | Gheuens Sarah | Chief Medical Officer | Sell | $452.6K |
8 filings